Veracyte, Inc.
Veracyte, Inc. logo
VCYT

Veracyte, Inc. (VCYT)

$25.83.26%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$25.16
Day's Range
$26.255
$14.85
52-Week Range
$33.23
1 month return19.12%
3 month return7.84%
1 year return11.51%
5 year return333.66%

Analyst Recommendation

based on 14 analysts ratings

Buy
78%
Buy
14%
Hold
7%
Sell

Based on 14 Wall street analysts offering stock ratings for Veracyte, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 20.81%

Current

$25.8

Target

$31.17

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
11
11
11
Hold
2
2
2
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization1.9B
Book Value$14.61
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-0.69
PEG Ratio0.0
Wall Street Target Price31.17

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)1.99
Enterprise Value1.9B
Enterprise Value/Revenue6.83
Enterprise Value/Ebitda-106.01

Technicals

Beta1.46
50 Day MA25.95
200 Day MA22.06

Institutional Holdings

ARK Investment Management LLC

11.57%

Vanguard Group Inc

9.42%

BlackRock Inc

8.58%

Wellington Management Company LLP

8.17%

State Street Corporation

7.28%

Artisan Partners Limited Partnership

5.31%

Company Information

Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company's growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company's tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte's exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California.
OrganizationVeracyte, Inc.
Employees761
CEOMs. Bonnie H. Anderson
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Veracyte, Inc. share price today?

Can Indians buy Veracyte, Inc. shares?

How can I buy Veracyte, Inc. shares from India?

Can Fractional shares of Veracyte, Inc. be purchased?

What are the documents required to start investing in Veracyte, Inc. stocks?

What are today’s High and Low prices of Veracyte, Inc.?

What are today’s traded volumes of Veracyte, Inc.?

What is today’s market capitalisation of Veracyte, Inc.?

What is the 52 Week High and Low Range of Veracyte, Inc.?

How much percentage Veracyte, Inc. is down from its 52 Week High?

How much percentage Veracyte, Inc. is up from its 52 Week low?

What are the historical returns of Veracyte, Inc.?

Who is the Chief Executive Officer (CEO) of Veracyte, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*